Novo Financial Statements From 2010 to 2026

Novo Nordisk Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 570 B 542.9 B 180 B Slightly volatile Short and Long Term Debt Total 137.5 B 131 B 27 B Slightly volatile Other Current Liabilities 193.1 B 183.9 B 62.8 B Slightly volatile Total Current Liabilities 226.4 B 215.7 B 80.1 B Slightly volatile Total Stockholder Equity 203.7 B 194 B 69.5 B Slightly volatile Property Plant And Equipment Net 218.8 B 208.4 B 61.3 B Slightly volatile Retained Earnings 205.1 B 195.3 B 69.3 B Slightly volatile Cash 27.8 B 26.5 B 13.8 B Slightly volatile Non Current Assets Total 389 B 370.4 B 105 B Slightly volatile Cash And Short Term Investments 28.3 B 27 B 17.6 B Slightly volatile Net Receivables 79.5 B 75.7 B 33.9 B Slightly volatile Common Stock Shares Outstanding 4.8 B 4.4 B 4.9 B Slightly volatile Liabilities And Stockholders Equity 570 B 542.9 B 180 B Slightly volatile Non Current Liabilities Total 139.9 B 133.2 B 30.4 B Slightly volatile Inventory 52.1 B 49.6 B 19.1 B Slightly volatile Total Liabilities 366.3 B 348.9 B 110.5 B Slightly volatile Property Plant And Equipment Gross 280.7 B 267.3 B 83.1 B Slightly volatile Total Current Assets 181.1 B 172.5 B 75 B Slightly volatile Short Term Debt 12.6 B 12 B 4 B Slightly volatile Intangible Assets 115.7 B 110.2 B 28.3 B Slightly volatile Accounts Payable 20.7 B 19.8 B 9.5 B Slightly volatile Common Stock Total Equity 493.1 M 423 M 514.1 M Slightly volatile Common Stock 446.8 M 401.4 M 459.2 M Slightly volatile Other Liabilities 15.1 B 14.4 B 6.5 B Slightly volatile Property Plant Equipment 218.8 B 208.4 B 61.9 B Slightly volatile Current Deferred Revenue 129.9 B 123.7 B 52.5 B Slightly volatile Other Assets 24.8 B 23.6 B 8.5 B Slightly volatile Net Tangible Assets 37 B 36.9 B 29.2 B Slightly volatile Long Term Investments 1.7 B 2.5 B 1.4 B Slightly volatile Net Invested Capital 332.3 B 316.4 B 106.3 B Slightly volatile Capital Stock 370.1 M 401.4 M 467.4 M Slightly volatile
Novo Nordisk Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 14.8 B 14.1 B 5.7 B Slightly volatile Selling General Administrative 6.4 B 5.2 B 4 B Slightly volatile Total Revenue 312.1 B 297.2 B 144.9 B Slightly volatile Gross Profit 250.7 B 238.8 B 120.2 B Slightly volatile Other Operating Expenses 175.7 B 167.4 B 83.1 B Slightly volatile Operating Income 136.3 B 129.8 B 61.8 B Slightly volatile EBIT 136.3 B 129.8 B 61 B Slightly volatile EBITDA 151.1 B 143.9 B 66.7 B Slightly volatile Cost Of Revenue 61.3 B 58.4 B 24.6 B Slightly volatile Total Operating Expenses 114.4 B 108.9 B 58.5 B Slightly volatile Income Before Tax 131.8 B 125.5 B 60.2 B Slightly volatile Net Income 103.4 B 98.5 B 47.7 B Slightly volatile Income Tax Expense 28.4 B 27 B 12.5 B Slightly volatile Research Development 52.5 B 50 B 21.2 B Slightly volatile Net Income Applicable To Common Shares 107.6 B 102.4 B 43.8 B Slightly volatile Selling And Marketing Expenses 36.5 B 62.7 B 34.3 B Slightly volatile Net Income From Continuing Ops 52.2 B 102.4 B 40.2 B Slightly volatile Tax Provision 15.9 B 28.1 B 12.8 B Slightly volatile Interest Income 3 B 2.9 B 3 B Slightly volatile Reconciled Depreciation 23.1 B 22 B 7.5 B Slightly volatile
Novo Nordisk Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 19.6 B 29 B 34.6 B Slightly volatile Begin Period Cash Flow 8.8 B 15.7 B 13 B Pretty Stable Depreciation 15.4 B 14.7 B 5.8 B Slightly volatile Capital Expenditures 94.6 B 90.1 B 22.5 B Slightly volatile Total Cash From Operating Activities 125.1 B 119.1 B 57.8 B Slightly volatile Net Income 107.6 B 102.4 B 48.2 B Slightly volatile End Period Cash Flow 27.8 B 26.5 B 15 B Slightly volatile Dividends Paid 52.3 B 49.8 B 22 B Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 3.86 4.6757 7.5006 Slightly volatile Dividend Yield 0.0376 0.0358 0.0198 Slightly volatile PTB Ratio 6.74 7.4471 15.5128 Slightly volatile Days Sales Outstanding 66.16 89.4053 86.7914 Slightly volatile Book Value Per Share 45.86 43.6748 16.1498 Slightly volatile Free Cash Flow Yield 0.0238 0.0408 0.0361 Slightly volatile Operating Cash Flow Per Share 28.15 26.8067 12.3688 Slightly volatile Stock Based Compensation To Revenue 0.0042 0.0083 0.0056 Slightly volatile Capex To Depreciation 4.31 4.1006 2.6829 Slightly volatile PB Ratio 6.74 7.4471 15.5128 Slightly volatile EV To Sales 3.81 5.0138 7.4533 Slightly volatile Free Cash Flow Per Share 13.93 13.2708 8.2483 Slightly volatile ROIC 0.22 0.2953 0.5008 Pretty Stable Inventory Turnover 1.69 1.1847 1.2665 Slightly volatile Net Income Per Share 24.21 23.0551 10.3092 Slightly volatile Days Of Inventory On Hand 214 308 293 Slightly volatile Payables Turnover 4.81 2.9754 3.1741 Slightly volatile Sales General And Administrative To Revenue 0.0183 0.0193 0.0331 Slightly volatile Research And Ddevelopement To Revenue 0.17 0.1684 0.1413 Pretty Stable Capex To Revenue 0.12 0.1946 0.1007 Slightly volatile Cash Per Share 6.37 6.0684 3.964 Slightly volatile POCF Ratio 14.56 12.1332 20.073 Pretty Stable Interest Coverage 17.89 18.8342 316 Slightly volatile Payout Ratio 0.27 0.5053 0.4181 Slightly volatile Capex To Operating Cash Flow 0.53 0.5049 0.2944 Pretty Stable PFCF Ratio 19.5 24.5088 28.3551 Slightly volatile Days Payables Outstanding 86.74 123 132 Slightly volatile Income Quality 1.44 1.1627 1.2475 Very volatile ROE 0.28 0.5279 0.6133 Pretty Stable EV To Operating Cash Flow 14.36 13.0105 19.9101 Slightly volatile PE Ratio 17.27 14.1075 23.7728 Slightly volatile Return On Tangible Assets 0.15 0.2481 0.3075 Pretty Stable EV To Free Cash Flow 20.05 26.281 28.0752 Slightly volatile Earnings Yield 0.0589 0.0709 0.0492 Slightly volatile Intangibles To Total Assets 0.25 0.2396 0.1039 Slightly volatile Current Ratio 0.76 0.7996 1.2586 Slightly volatile Tangible Book Value Per Share 15.12 14.4033 8.5836 Slightly volatile Receivables Turnover 5.28 4.0825 4.3747 Slightly volatile Graham Number 158 151 60.9724 Slightly volatile Shareholders Equity Per Share 45.86 43.6748 16.1498 Slightly volatile Debt To Equity 0.71 0.6749 0.2102 Slightly volatile Capex Per Share 14.21 13.5359 4.1199 Slightly volatile Revenue Per Share 73.04 69.562 31.1946 Slightly volatile Interest Debt Per Share 32.55 31.0007 6.4564 Slightly volatile Debt To Assets 0.25 0.2412 0.078 Slightly volatile Enterprise Value Over EBITDA 11.16 10.3693 16.9041 Slightly volatile Short Term Coverage Ratios 9.42 9.9111 54.4702 Pretty Stable Price Earnings Ratio 17.27 14.1075 23.7728 Slightly volatile Operating Cycle 280 398 380 Slightly volatile Price Book Value Ratio 6.74 7.4471 15.5128 Slightly volatile Days Of Payables Outstanding 86.74 123 132 Slightly volatile Dividend Payout Ratio 0.27 0.5053 0.4181 Slightly volatile Price To Operating Cash Flows Ratio 14.56 12.1332 20.073 Pretty Stable Price To Free Cash Flows Ratio 19.5 24.5088 28.3551 Slightly volatile Pretax Profit Margin 0.22 0.4224 0.3836 Slightly volatile Ebt Per Ebit 1.2 1.0226 1.0047 Very volatile Operating Profit Margin 0.22 0.413 0.3895 Pretty Stable Effective Tax Rate 0.3 0.2153 0.2194 Pretty Stable Company Equity Multiplier 1.46 2.7978 2.1924 Slightly volatile Long Term Debt To Capitalization 0.38 0.3653 0.1641 Slightly volatile Total Debt To Capitalization 0.42 0.4029 0.1431 Slightly volatile Return On Capital Employed 0.3 0.3901 0.6535 Pretty Stable Debt Equity Ratio 0.71 0.6749 0.2102 Slightly volatile Ebit Per Revenue 0.22 0.413 0.3895 Pretty Stable Quick Ratio 0.54 0.5696 0.9372 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.24 1.0643 1.6265 Slightly volatile Net Income Per E B T 0.59 0.7847 0.7741 Very volatile Cash Ratio 0.12 0.1227 0.348 Slightly volatile Cash Conversion Cycle 204 275 252 Pretty Stable Operating Cash Flow Sales Ratio 0.22 0.3854 0.3605 Slightly volatile Days Of Inventory Outstanding 214 308 293 Slightly volatile Days Of Sales Outstanding 66.16 89.4053 86.7914 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.42 0.4951 0.7027 Slightly volatile Cash Flow Coverage Ratios 0.86 0.9095 36.4611 Slightly volatile Price To Book Ratio 6.74 7.4471 15.5128 Slightly volatile Fixed Asset Turnover 1.7 1.4832 2.7809 Slightly volatile Capital Expenditure Coverage Ratio 2.68 1.9804 4.5629 Slightly volatile Price Cash Flow Ratio 14.56 12.1332 20.073 Pretty Stable Enterprise Value Multiple 11.16 10.3693 16.9041 Slightly volatile Debt Ratio 0.25 0.2412 0.078 Slightly volatile Cash Flow To Debt Ratio 0.86 0.9095 36.4611 Slightly volatile Price Sales Ratio 3.86 4.6757 7.5006 Slightly volatile Return On Assets 0.14 0.1887 0.2796 Slightly volatile Asset Turnover 0.65 0.5693 0.9075 Slightly volatile Net Profit Margin 0.17 0.3314 0.3024 Slightly volatile Gross Profit Margin 0.58 0.8098 0.8006 Very volatile Price Fair Value 6.74 7.4471 15.5128 Slightly volatile Return On Equity 0.28 0.5279 0.6133 Pretty Stable
Novo Nordisk Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 644.9 B 614.2 B 616.3 B Slightly volatile Enterprise Value 632 B 601.9 B 603.8 B Slightly volatile

Novo Fundamental Market Drivers

Novo Upcoming Events

About Novo Nordisk Financial Statements

Pair Trading with Novo Nordisk

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novo Nordisk position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will appreciate offsetting losses from the drop in the long position's value.When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:

How To Invest In Novo Details

Is Novo Stock a good investment? Details

What is Novo Nordisk's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details